Pharmacie de Bousval SA
Pharmacie de Bousval reported total assets of 139,616 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026).
The score of Pharmacie de Bousval shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -47 % Total assets -44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie de Bousval's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 23 May 2022
Pharmacie de Bousval's financial analysis
- Solvency42.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie de Bousval
Pharmacie de Bousval's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.811.884
- VAT number
- BE0479811884
- Peppol
- Registered · 0208:0479811884 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Mar 2003
- Registered office
- 1470 Genappe
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie de Bousval (SA) has been based in Genappe since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 16,998 € and equity of 59,775 €; its revenue is not published. Its solvency stands at 42.8%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie de Bousval
Companies in the same business, of comparable size and area, outside its group.
- RiethPharma Retail sale of pharmaceutical products Mortsel · balance sheet 138,933 €
- Apotheker Bosmans Kristien Retail sale of pharmaceutical products Merchtem · balance sheet 138,175 €
- Sirona Pharma Retail sale of pharmaceutical products Etterbeek · balance sheet 138,027 €
- C.V.Pharma Retail sale of pharmaceutical products Les Bons Villers · balance sheet 137,101 €
- Commuphar Retail sale of pharmaceutical products Antwerp · balance sheet 136,781 €
- Apotheek Houben - Swinnen Retail sale of pharmaceutical products Genk · balance sheet 145,008 €
- Laura Cufaro Retail sale of pharmaceutical products Engis · balance sheet 145,385 €
- Jetpharma Retail sale of pharmaceutical products Jette · balance sheet 146,419 €
Frequently asked questions about Pharmacie de Bousval
What is the revenue of Pharmacie de Bousval?
Pharmacie de Bousval files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie de Bousval?
In Belgium, the VAT number is the company number prefixed with BE: BE0479811884 for Pharmacie de Bousval, if the company is VAT-registered. Its company number (CBE) is 0479.811.884.
Where is the registered office of Pharmacie de Bousval?
According to the CBE register, the registered office of Pharmacie de Bousval is in 1470 Genappe.
What is the equity of Pharmacie de Bousval?
At the close of the 2025 financial year, the equity of Pharmacie de Bousval amounts to 59,775 €, a solvency of 42.8% of total assets.
Who manages Pharmacie de Bousval?
The register lists 2 active mandates at Pharmacie de Bousval. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie de Bousval
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →